IM Cannabis Corp. Files Q3 2025 Financial Results

TL;DR

IM Cannabis Corp. dropped its Q3 2025 financials, check the 6-K for the details.

AI Summary

IM Cannabis Corp. filed a Form 6-K on November 13, 2025, reporting its unaudited interim condensed consolidated financial statements for the three and nine months ended September 30, 2025. The filing also includes Management's Discussion and Analysis of Financial Condition and Results of Operations for the same periods. This report is filed under the Securities Exchange Act of 1934.

Why It Matters

This filing provides investors with an update on IM Cannabis Corp.'s financial performance and operational status for the third quarter of 2025, crucial for assessing the company's health and future prospects.

Risk Assessment

Risk Level: medium — As a foreign private issuer in the cannabis industry, IM Cannabis Corp. faces regulatory, market, and operational risks that could impact its financial performance.

Key Players & Entities

• IM Cannabis Corp. (company) — Registrant
• 001-40065 (company) — SEC File Number
• November 2025 (date) — Reporting Period
• September 30, 2025 (date) — Financial Statement Period End

FAQ

From the Filing

0001178913-25-003806.txt : 20251113 0001178913-25-003806.hdr.sgml : 20251113 20251113091606 ACCESSION NUMBER: 0001178913-25-003806 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20251113 FILED AS OF DATE: 20251113 DATE AS OF CHANGE: 20251113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IM Cannabis Corp. CENTRAL INDEX KEY: 0001792030 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40065 FILM NUMBER: 251475777 BUSINESS ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 BUSINESS PHONE: 416-256-4202 MAIL ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 6-K 1 zk2533977.htm 6-K   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of November 2025   (Report No. 2) .   Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) Kibbutz Glil Yam, Central District, Israel 4690500 (Address of principal executive offices)   Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒      Form 40-F ☐   This Report of Foreign Private Issuer on Form 6-K consists of IM Cannabis Corp.’s (the “Company”): (i) Unaudited Interim Condensed Consolidated Financial Statements for the three and nine months ended September 30, 2025, which are attached hereto as Exhibit 99.2; (ii) Management’s Discussion and Analysis of Financial Condition and Results of Operations for the three and nine months ended September 30, 2025, which is attached hereto as Exhibit 99.3; and (iii) a press release issued by the Company on September 13, 2025 titled “IM Cannabis Reports Third Quarter 2025 Financial Results”, which is attached hereto as Exhibit 99.1. This Report of Foreign Private Issuer on Form 6-K, excluding the section titled “Management Commentary” of Exhibit 99.1, Exhibit 99.4 and Exhibit 99.5 hereto, is incorporated by reference into the Company’s Registration Statements on Form F-3 (File No.  333-288346  and File No. 333-289571 ) filed with the Securities and Exchange Commission to be a part thereof from the date on which this Report of Foreign Private Issuer on Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.   EXHIBIT INDEX   99.1 News Release dated November 13, 2025 99.2 Interim Consolidated Financial Statements for the three and nine months ended September 30, 2025 99.3 Management's Discussion and Analysis for the three and nine months ended September 30, 2025 99.4 Certification of Interim Filings by CFO dated November 13, 2025 99.5 Certification of Interim Filings by CEO dated November 13, 2025 SIGNATURE   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.     IM CANNABIS CORP.   (Registrant)       Date: November 13, 2025 By: /s/ Oren Shuster   Name: Oren Shuster   Title: Chief Executive Officer and Director EX-99.1 2 exhibit_99-1.htm EXHIBIT 99.1 Exhibit 99.1 IM Cannabis Reports Third Quarter 2025 Financial Results   TORONTO and GLIL YAM, Israel, November 13, 2025 /PRNewswire/ -- IM Cannabis Corp. (the " Company " or " IMC ") (NASDAQ: IMCC), an international medical cannabis company, announced its financial results today for the third quarter and nine months ended September 30, 2025. All amounts are reported i